Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer

European Journal of Cancer

Volumn 38, Issue 9, 2002, Pages 1212-1217

  De Lange, S M ^a   Van Groeningen, C J ^a   Meijer, O W M ^a   Cuesta, M A ^a   Langendijk, J A ^a   Van Riel, J M G H ^b   Pinedo, H M ^a   Peters, G J ^a   Meijer, S ^a   Slotman, B J ^a   Giaccone, G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CPRLab   (Netherlands)

Author keywords

Gemcitabine; Locally advanced pancreatic cancer; Radiotherapy

Indexed keywords

GEMCITABINE;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; FEVER; FISTULA; HUMAN; LEUKOPENIA; MALE; NAUSEA; PANCREAS CANCER; PATHOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; STOMACH HEMORRHAGE; STOMACH ULCER; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036277568     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00076-X     Document Type: Article

References (28)

1. Cancer statistics
2. Current chemotherapeutic possibilities in pancreaticobiliairy cancer
3. Cancer of the pancreas: 50 years of surgery
4. Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer
5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial
6. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000rads) radiation alone, moderate dose radiation (4000rads)+ 5-fluorouracil, and high dose radiation+ 5-fluorouracil
7. Radiotherapy for carcinoma of the pancreas
8. Maximizing therapeutic gain with gemcitabine and fractionated radiation
9. Radiosensitization of Human Solid Tumor Cell Lines With Gemcitabine
10. Enhancement of tumor radioresponse in vivo by gemcitabine
11. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation on sensitization of human colon carcinoma cells
12. Endjoining deficiency and radiosensititation induced by gemcitabine
13. Chemo-radiotherapy: Radiosensitizing nucleoside analogues
14. Aorto-duodenal fistula following abdominal irradiation for Hodgkin's disease, a case report
15. Phase II trial of gemcitabine (2′,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
16. Gemcitabine plus radiotherapy for non-small cell lung cancer
17. A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy and concomitant chemoradiotherapy for unresectable stage III non-small cell lung cancer
18. Prospective audit following the introduction of short-course pre-operative radiotherapy for rectal cancer
19. Intrinsic radiosensitivity of human pancreatic tumor cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside
20. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma
21. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer
22. Phase I trial of radiation dose escalation with concurrent weekly full dose gemcitabine in patients with advanced pancreatic cancer
23. A phase I study of gemcitabine in combination with radiation therapy in patients with localized unresectable pancreatic cancer
24. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
25. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas
26. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer